NCT02190695 2021-05-19Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDSFox Chase Cancer CenterPhase 2 Completed92 enrolled
NCT00020969 2020-10-05Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesCTI BioPharmaPhase 2 Terminated
NCT00104806 2018-08-10Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic SyndromesWake Forest University Health SciencesPhase 2 Terminated5 enrolled
NCT00118196 2018-05-11Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaMedical University of South CarolinaPhase 2 Terminated1 enrolled
NCT00003885 2013-11-06Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or MyelomaNational Cancer Institute (NCI)Phase 2 Unknown60 enrolled